News Focus
News Focus
Followers 42
Posts 2198
Boards Moderated 0
Alias Born 02/10/2014

Re: Monroe1 post# 86433

Monday, 06/22/2020 4:48:54 PM

Monday, June 22, 2020 4:48:54 PM

Post# of 236580
Monroe, I’m sure you and many others on this board see Leronlimab for what it is. A term I like to coin is an: IDM (Industry Disrupting Molecule). It’s broad application and zero side effects profile makes this drug best in class for decades to come. This company will not look the same 1 year from today, if not 6 months. NP is very ambitious, to say the least, About having ten clinical trials by the end of this year... but if this molecule works the way we think and have seen to, ambitious will only be in relation to how many trials we can start, and not necessarily the indications they pursue. Best of luck all! See ya in December!!!!!

All my posts, comments, and investments are not to be considered investment advice in any way.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News